MedPath

The effect of oral melatonin before percutaneous nephrolithotomy surgery

Phase 3
Conditions
Kidney stones.
Calculus of lower urinary tract
Registration Number
IRCT20190624043991N26
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
104
Inclusion Criteria

Patients in the age range of 20 to 55 years
Candidate for PCNL surgery under general anesthesia
Written and informed consent from patients

Exclusion Criteria

Neuro-psychiatric diseases such as depression and schizophrenia
Heart diseases and brain treatment
The use of sedatives and beta blockers and sleeping pills or pain relievers
Existence of drug sensitivity
Estimated duration of anesthesia>4 hours

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the incidence of SIRS caused by percutaneous nephrolithotomy (PCNL) due to the use and non-use of melatonin. Timepoint: 24 to 48 hours after the operation. Method of measurement: Medical laboratory.;Changes in the incidence of sepsis caused by percutaneous nephrolithotomy (PCNL) due to the use and non-use of melatonin. Timepoint: 24 to 48 hours after the operation. Method of measurement: Medical laboratory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath